Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: Predictive value of DNA-PK and phosphorylated ACC

Francesco Perrone, Gustavo Baldassarre, Stefano Indraccolo, Simona Signoriello, Gennaro Chiappetta, Francesca Esposito, Gabriella Ferrandina, Renato Franco, Delia Mezzanzanica, Maura Sonego, Elisabetta Zulato, Gian Franco Zannoni, Vincenzo Canzonieri, Giovanni Scambia, Roberto Sorio, Antonella Savarese, Enrico Breda, P. Scollo, Antonella Ferro, Stefano TamberiAntonio Febbraro, D. Natale, Massimo Di Maio, Daniela Califano, Giosuè Scognamiglio, Domenica Lorusso, Sitvana Canevari, Nunzia Simona Losito, Ciro Gallo, Sandro Pignata

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: Predictive value of DNA-PK and phosphorylated ACC'. Together they form a unique fingerprint.

Medicine & Life Sciences